INNV Stock UPDATES Innovus Pharmaceuticals Inc (INNV) 0.4000

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Innovus Pharmaceuticals Inc (INNV) 0.4000 $INNV

Innovus Pharmaceuticals signs non-exclusive sampling, marketing and distribution agreement for Zestra in the US
M2 - Tue Sep 09, 6:42AM CDT
Innovus Pharmaceuticals (Other OTC:INNV), a provider of sexual dysfunction products, revealed on Monday the launch of an non-exclusive sampling, marketing and distribution agreement for Zestra with Bulu Bo.

Innovus Pharmaceuticals, Inc. (OTCQB:INNV), Exclusive Interview for Interlinked's Investment News Channel
PRWeb - Mon Sep 08, 6:05AM CDT
Innovus Pharma was one of the presenting companies at the recent FSXinterlinked Investment Conference, held at the Four Seasons Hotel in Westlake Village, California.

Innovus Pharma Expands US Distribution by Signing a Non-Exclusive Sampling and Distribution Agreement With Bulu Box(R) for Zestra(R) in the US
GlobeNewswire - Mon Sep 08, 5:00AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCQB:INNV), announced today it has entered into an non-exclusive sampling, marketing and distribution agreement with Bulu Box(R) ("Bulu Box" under which Bulu Box will add Zestra(R) as part of its monthly box to all current subscribers. In addition, Bulu Box will sell Zestra(R) 3 packettes box through its E-commerce platform in the US.

Innovus Pharma to Present at the 2014 Aegis Healthcare Conference in Las Vegas, NV and the See Thru Equity Fall Microcap Investor Conference in New York
GlobeNewswire - Thu Sep 04, 5:00AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, President & CEO of the Company is scheduled to present at the 2014 Aegis Healthcare Conference to be held September 10-13, 2014 at The Encore at Wynn Las Vegas. The Company's presentation will be on Friday, September 12th at 8:00 a.m. PDT.

Innovus Pharma to market and distribute Zestra for alternative markets through DanaLife ApS
M2 - Thu Aug 28, 6:56AM CDT
Pharmaceutical company Innovus Pharmaceuticals (Other OTC:INNV) Thursday executed an exclusive marketing and distribution agreement to grant the worldwide distribution right (excluding Canada) to market and sell its topical consumer care product Zestra in the alternative markets that excludes all medical and mainstream sales channels.

Innovus Pharma Signs Exclusive Marketing and Distribution Agreement With DanaLife ApS to Market and Distribute Zestra(R) for Alternative Markets
GlobeNewswire - Thu Aug 28, 5:21AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCQB:INNV) announced today it has entered into an exclusive marketing and distribution agreement with DanaLife ApS based in Denmark ("DanaLife" under which Innovus Pharma has granted to DanaLife an exclusive 18 month worldwide distribution right ( excluding Canada) , to market and sell Innovus Pharma's topical consumer care product to increase Female Sexual Arousal and Desire and Satisfaction, Zestra(R) for the alternative markets which excludes all medical and mainstream sales channels. The Company is in the process of negotiating commercial agreements with Pharmaceutical companies to promote the product in the medical and mainstream channels. Under the agreement the initial minimum orders are expected to be two hundred and fifty thousand US dollars. The terms of the agreement can be extended automatically by another 18 months if DanaLife meets certain minimum sales numbers.

Innovus Announces Formation of a Global Clinical Advisory Board to Support the Growth of Its Product Zestra(R)
GlobeNewswire - Thu Aug 21, 5:25AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or "Company" (www.innovuspharma.com) (OTCQB:INNV), announced today the formation of a Clinical Advisory Board made up of top key opinion leaders in the fields of gynecology and sexual health to support the continued growth of its Zestra product. The Clinical Advisory Board will work closely with the Innovus Pharma management team in addressing health authorities, outlining clinical protocols and surveys, as well as presenting Innovus Pharma at academic and industry meetings for its marketed and currently in-development products.

Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction
GlobeNewswire - Fri Aug 15, 5:00AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) a leader in over-the-counter ("OTC" and consumer care products for men and women's sexual dysfunction and health products announced today that its U.S. sales and marketing partner, Consortia Health, began recently the detailing of its Zestra(R) product clinically proven to enhance arousal, desire and satisfaction in women to gynecologists in 13 states. Consortia's 25 member sales force is composed of sales representatives and nurse practitioners. The sales force currently covers over 50% of the US population in the following U.S. states: Pennsylvania, Michigan, Nevada, Texas, Florida, Louisiana, Georgia, New York, New Jersey, Colorado, Washington, Utah, California, North Carolina and Arizona.

Innovus Pharma awarded higher line of credit of USD1.5m from CEO
M2 - Thu Aug 07, 7:03AM CDT
Sexual dysfunction company Innovus Pharmaceuticals (Other OTC:INNV) reported on Wednesday a rise in its line of credit with its president and CEO, Dr Bassam Damaj, to USD1.5m.

Innovus Pharma Secures Additional Funding by Increasing Its Line of Credit With Its Chief Executive Officer to $1.5M, Provides Quarter Update and Timing of Its 10-Q Filing
GlobeNewswire - Wed Aug 06, 5:01AM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCQB:INNV) today announced that the Company increased its Line of Credit with Dr. Bassam Damaj, its President & CEO to a total of $1.5M. This added funding combined with the revenues from sales of commercial products both in the US and Canada, as well as from the new international partnerships the Company expects to announce this year, the Company believes, will provide a cash runway until Q2 2015. "My strong belief in the success of the Company and its commercial pipeline makes my commitment to Innovus unwavering," said Dr. Damaj, President & Chief Executive Officer of the Company.

Innovus Pharma to Present at the FSXinterlinked Financial Investment Conference in Westlake Village, CA
GlobeNewswire - Mon Jul 28, 1:32PM CDT
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCBB:INNV) today announced that Dr. Bassam Damaj, President & CEO of the Company will present to an audience of principals and key decision makers of broker/dealers and financial firms at the FSXinterlinked Financial Investment Conference to be held at the Four Season Westlake Village, California from July 30-August 2, 2014. The presentation will take place on Thursday, July 31, 2014 at 1:57pm.

Innovus Pharma Provides Corporate Update
ACCESSWIRE - Wed Jun 25, 5:29AM CDT
San Diego, CA / ACCESSWIRE / June 25, 2014 / Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company" (OTCBB: INNV) (http://www.innovuspharma.com/) announced today a corporate mid-year update covering Company activities, expected near-term events and comments on recent market conditions, as follows:

Personal Accident and Health Insurance in Greece, Key Trends and Opportunities to 2017
M2 - Wed Feb 26, 4:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/bjj4j7/personal_accident) has announced the addition of the "Personal Accident and Health Insurance in Greece, Key Trends and Opportunities to 2017" report to their offering. The Greek personal accident and health insurance segment accounted for the lowest share of premiums in the overall insurance industry in 2012. Demand for healthcare services and private health insurance increased during the review period (2008-2012), due to the inadequate service provided by public healthcare institutions and increasing per capita healthcare expenditure. Travel insurance accounted for the largest share of the segment. Growth in the category was supported by the introduction of low-cost airlines which increased the number of outbound tourists. Over the forecast period (2012-2017), the growth of the personal accident and health segment is expected to be driven by the travel and health insurance categories. Overall, the value of the Greek personal accident and health segment is expected to increase at a forecast-period compound annual growth rate (CAGR) of 5.5%. Key Topics Covered 1 Executive Summary 2 Introduction 3 Greek Insurance Industry Attractiveness 4 Personal Accident and Health Insurance Segment Outlook 5 Analysis by Distribution Channels 6 Porter's Five Forces Analysis - Greek Personal Accident and Health Insurance 7 Reinsurance Growth Dynamics and Challenges 8 Governance, Risk and Compliance 9 Competitive Landscape and Strategic Insights 10 Business Environment and Country Risk 11 Appendix Companies Mentioned - Eurolife - ING Greek Life Insurance - Metlife Alico For more information visit http://www.researchandmarkets.com/research/bj...l_accident About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.

Innovus Pharma reports market launch of EjectDelay in the US
M2 - Mon Feb 24, 7:02AM CST
Pharmaceuticals company Innovus Pharmaceuticals (Other OTC:INNV) disclosed on Friday the market availability of its over the counter (OTC) benzocaine-based topical premature ejaculation treatment, EjectDelay, in the US.

Innovus Pharma Announces Availability of EjectDelay(TM) for Premature Ejaculation in the United States
GlobeNewswire - Fri Feb 21, 5:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTCBB:INNV) today announced the availability of its over the counter ("OTC" benzocaine-based topical premature ejaculation treatment EjectDelay(TM) in the United States ("U.S." .

Innovus Pharma to Exhibit Zestra(R) its Clinically Proven Product for Female Sexual Arousal and Desire at the International Society for the Study of Women's Sexual Health 2014 Annual Meeting in San Diego
GlobeNewswire - Thu Feb 20, 9:00AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company" www.innovuspharma.com (OTC BB:INNV) today announced that it will exhibit Zestra(R), its topical over the counter ("OTC" product for female sexual arousal and desire at the 2014 Annual International Society for the Study of Women's Sexual Health Meeting in San Diego from February 20-22, 2014.

Innovus Pharmaceuticals Inc elects Lynnette Dillen as CFO & EVP
M2 - Wed Feb 12, 4:23AM CST
Sexual dysfunction products company Innovus Pharmaceuticals Inc (Other OTC:INNV) revealed on Tuesday the appointment of Lynnette Dillen as executive vice president and chief financial officer for its finance, accounting, human resources, information technology and investor relations.

Innovus Pharma Expands Management Team and Adds Chief Financial Officer
GlobeNewswire - Tue Feb 11, 5:15AM CST
Innovus Pharmaceuticals, Inc., ("Innovus Pharma" www.innovuspharma.com (OTCBB:INNV), today announced that Lynnette Dillen has joined the company as Executive Vice President and Chief Financial Officer with responsibility for finance, accounting, human resources, information technology and investor relations.

Innovus Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference in New York
GlobeNewswire - Wed Feb 05, 5:00AM CST
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company" , www.innovuspharma.com, (OTCBB:INNV) today announced that Dr. Bassam Damaj, Ph.D., Chief Executive Officer and President, will present at the 16th Annual BIO CEO & Investor Conference, to be held at the Waldorf-Astoria Hotel in New York February 10-11, 2014. Dr. Damaj is scheduled to present on Monday, February 10th at 11:00 a.m. EST in the Conrad Room. Dr. Damaj will give an overview of the Company and discuss the recent acquisition of Semprae Laboratories, Inc., the Company's growing pipeline and its projected growth. In addition, he will preview the recent accomplishments of the Company and the upcoming milestones.

TRENDnet(R) 720p Cloud Cameras Now Available
Marketwire - Tue Feb 04, 6:44AM CST
TRENDnet, a best-in-class wired and wireless networking hardware brand, today announces the availability of the HD Wireless Day / Night Cloud Camera (model TV-IP762IC) and HD Wireless Day / Night PTZ Cloud Camera (model TV-IP862IC).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Babe Ruth Lots Lead Morphy's $2 Million Collectibles Auction

Updated Category News Views 0

Ruth still pulls money like few names ever will, and Morphy's November 10-12 auction made that plain without any circus tricks. Three lots tied to the Yankees legend produced $136,500 within a Toys, Sports & General Collectibles sale that topped $2 million. That is not some vague nostalgia story. Buyers put real dollars behind a 1932 U.S. Caramel card, a 1933 Goudey card,...

Continue Reading
CMS Audit Proposal Reopens Medicare Advantage Risk

Updated Category News Views 104

A regulator just tossed a rusted anchor into managed care's earnings model. CMS's proposed Comprehensive Regulations to Uncover Suspicious Healthcare rule, dubbed CRUSH and numbered CMS-6098-P, puts Medicare Advantage risk-adjustment audits back at center stage. The headline nobody can casually wave away: audit findings from sampled enrollees could be extrapolated across...

Continue Reading
PG&E's $456 Million Interim Hike Faces a New Test Soon

Updated Category News Views 138

A utility can call a charge interim, but households still see the bill arrive in full. That is why the California Public Utilities Commission's unanimous approval of $456 million in interim rate recovery for Pacific Gas & Electric has landed with such rotten timing. The money is set to begin flowing from customers on January 1, 2027, while major questions about PG&E's...

Continue Reading
Cybersecurity's AI Tailwind Meets a Brutal Market Test

Updated Category News Views 89

Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
IAS Marks 42 Years Amid Germany Religious Freedom Win

Updated Category News Views 96

Bagpipes, country roads and a gathering from six continents made this far more than a routine anniversary reception. The International Association of Scientologists marked its 42nd anniversary at Saint Hill in East Grinstead, England, with thousands of Scientologists and guests arriving as autumn settled over West Sussex. That sort of turnout is a visible statement of...

Continue Reading
Dario's Personify Panel Puts Distribution Model in Focus

Updated Category News Views 121

A Partner Megaphone Is Not a Revenue Line Monday's virtual panel gives DarioHealth a useful stage, but investors should not confuse a conference microphone with a signed sales order. Erez Raphael is set to lead a November 23 discussion with Personify Health President Ed Liebowitz at the U.S. Bancorp | BTIG Tech-Enabled Healthcare Forum, running from noon to 12:50 p.m....

Continue Reading
Mobile Core's Cost Crunch Favors Telecom's Big Three

Updated Category News Views 45

Server bills have finally crashed the party in mobile core, and nobody should pretend that is a minor inconvenience. Dell'Oro Group's 3Q 2026 read is blunt: Mobile Core Network revenue growth was lackluster because 5G spending came in below expectations, while higher server costs pushed operators to reshuffle priorities, postpone projects, and keep 4G core gear alive...

Continue Reading
PTC Pushes Deeper Into Federal Product Development

Updated Category News Views 82

Federal engineering software is a miserable place to show up late, and PTC is plainly trying not to. Its November 19, 2026 expansion brings Windchill+ onto Microsoft Azure Government through PTC Cloud Services and introduces Onshape Government Federal for teams handling Controlled Unclassified Information. This is not a glamorous product refresh. It is a bid to remove the...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 130

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth in Edge Data Center Market Through 2029

Updated Category News Views 227

Edge Data Center Market Outlook and Growth Drivers The edge data center market is set to witness impressive growth, with projections estimating an increase of USD 45.1 billion from 2025 to 2029. This surge is driven primarily by the rising demand for video streaming services and the incorporation of artificial intelligence (AI) in data center operations. Market Trends...

Continue Reading
Uncertainties Loom as U.S. Economy Reacts to Job Data Shift

Updated Category News Views 73

Economic Uncertainties Fueling Market Volatility Recent fluctuations in the U.S. economy have raised fresh concerns among investors, particularly as key employment data shows an unexpected slowdown. This situation has intensified worries about the Federal Reserve's monetary policies and the approaching U.S. presidential election season, creating a tough environment for...

Continue Reading
SME Insurance Market Expected to Surge to $45.60 Billion

Updated Category News Views 96

Growth of the SME Insurance Market Recent data shows that the global SME insurance market, currently valued at around USD 28 billion, is projected to surge to USD 45.60 billion in the coming years. This significant growth is primarily driven by the rising number of small and medium enterprises (SMEs) that need comprehensive insurance solutions to protect themselves from...

Continue Reading
Unlocking High-Yield Potential with CoinEx Dual Investment

Updated Category News Views 199

Introducing CoinEx Dual Investment CoinEx, a leading cryptocurrency exchange, has unveiled its latest offering: CoinEx Dual Investment. This innovative investment product is tailored for users seeking to maximize their returns through a unique dual-currency settlement structure. With the cryptocurrency market showing constant fluctuations, this new option empowers users...

Continue Reading
Shelby County Federal Credit Union Enhances Leadership for Growth

Updated Category News Views 160

Welcoming a New Era at Shelby County Federal Credit Union Shelby County Federal Credit Union is beginning an exciting chapter as it welcomes its newly appointed Chief Executive Officer, Raffael Crockett. With more than thirty years in the credit union sector, Crockett is renowned for his transformational leadership capabilities. His vision is set on enhancing the...

Continue Reading